Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA
Article in Drugs & Therapy Perspectives (February 2024)
The most recent citing publications are shown below. View all 34 publications that cite this research output on Dimensions.
Article in Drugs & Therapy Perspectives (February 2024)
Article in Journal of Substance Use and Addiction Treatment (August 2023)
Article in Therapie (July 2023)